We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Atopix Therapeutics Awarded Biomedical Catalyst Grant

News   May 30, 2013

 
Atopix Therapeutics Awarded Biomedical Catalyst Grant
 
 
 

RELATED ARTICLES

Treating Blood Cancers With a Low-cost Arthritis Drug

News

A simple arthritis drug could be an effective, low-cost solution to treat patients with blood cancers, according to a new study by the University of Sheffield.

READ MORE

Potential Carcinogen Present in High Levels in E-cigarette Liquids

News

A potential carcinogen called "pulegone" is present in high levels in electronic cigarette liquids and smokeless tobacco products, according to a new study.

READ MORE

B Cells May Be More Important in Immunotherapy Than Previously Thought

News

Researchers have found evidence that B cells might play an important role in immunotherapy for melanoma. Currently, immunotherapy is primarily focused on T cells, but the results suggest that B cells could also provide an interesting research avenue.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE